Abstract
Colon cancer is among the most common cancers and the third cause of cancer deaths worldwide. If detected at an early stage, treatment might often lead to cure. The present review adduces the so far studied alterations in the expression of genes, as well as polymorphisms of genes engaged in DNA repair systems, with particular emphasis on indirect ones that are correlated with colorectal cancer. Such aberrations could be linked to an increased risk for the development of colorectal cancer and might serve as potential targets in the areas of prevention and therapy.
Keywords: Biomarker, colorectal carcinogenesis, DNA repair, gene polymorphism, genetic instability, genetic predisposition, mutations, familial adenomatous polyposis (FAP) syndrome, microsatellite instability, replication, DNA double helix, chromatid, DNA polymerase, pyrimidine dimers, photolyase
Current Molecular Medicine
Title: DNA Repair Mechanisms in Colorectal Carcinogenesis
Volume: 12 Issue: 3
Author(s): C. Michailidi, A. G. Papavassiliou and C. Troungos
Affiliation:
Keywords: Biomarker, colorectal carcinogenesis, DNA repair, gene polymorphism, genetic instability, genetic predisposition, mutations, familial adenomatous polyposis (FAP) syndrome, microsatellite instability, replication, DNA double helix, chromatid, DNA polymerase, pyrimidine dimers, photolyase
Abstract: Colon cancer is among the most common cancers and the third cause of cancer deaths worldwide. If detected at an early stage, treatment might often lead to cure. The present review adduces the so far studied alterations in the expression of genes, as well as polymorphisms of genes engaged in DNA repair systems, with particular emphasis on indirect ones that are correlated with colorectal cancer. Such aberrations could be linked to an increased risk for the development of colorectal cancer and might serve as potential targets in the areas of prevention and therapy.
Export Options
About this article
Cite this article as:
Michailidi C., G. Papavassiliou A. and Troungos C., DNA Repair Mechanisms in Colorectal Carcinogenesis, Current Molecular Medicine 2012; 12 (3) . https://dx.doi.org/10.2174/156652412799218859
DOI https://dx.doi.org/10.2174/156652412799218859 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biochemical Mechanisms of Cisplatin Cytotoxicity
Anti-Cancer Agents in Medicinal Chemistry Mitochondria: A Promising Target for Anticancer Alkaloids
Current Topics in Medicinal Chemistry Past, Present and Future of Targeted Therapy in Solid Tumors
Current Cancer Drug Targets Effectiveness and Tolerability of Very-low Volume Preparation for Colonoscopy: A Narrative Review
Current Drug Metabolism Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets Recent Developments in the Pharmacological Properties of 4'-Geranyloxyferulic Acid, a Colon Cancer Chemopreventive Agent of Natural Origin
Current Drug Targets Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Current Drug Targets Cellular Senescence and Anti-Cancer Therapy
Current Drug Targets Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Anti-Cancer Agents in Medicinal Chemistry Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy MicroRNAs as Cancer Biomarkers
MicroRNA Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
Current Genomics Endothelin-1 and Angiogenesis in Cancer
Current Vascular Pharmacology Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets Tumor Stroma as a Target in Cancer
Current Cancer Drug Targets The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Current Medicinal Chemistry Combined Effect of Parthenolide and Various Anti-cancer Drugs or Anticancer Candidate Substances on Malignant Cells in vitro and in vivo
Mini-Reviews in Medicinal Chemistry Recent Patents on Alphavirus Protein Expression and Vector Production
Recent Patents on Biotechnology Targeting: The ADEPT Story So Far
Current Drug Targets